Sibelius focuses on the need to support healthy ageing and the increasing market demand for branded, scientifically evidenced, clinically proven natural products.

Founded in late 2015, from a spin-out of Oxford University, our patented Chronoscreen™ platform brings new, cost-effective tools to respond to these issues, utilising the validated model organism Caenorhabditis elegans to rapidly identify natural products that have the potential for beneficial effects on human health. Our platform permits exploration of the molecular basis of activity, and provides the science to support investment in clinical trials. It also allows screening to identify novel ingredients, improved sources, and synergistic mixtures.